Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cabergoline Effect on Blood Sugar in Type 2 Diabetics

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2011 by Mashhad University of Medical Sciences.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Haleh Rokni Yazdi, Mashhad University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01459601
First received: October 24, 2011
Last updated: NA
Last verified: October 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: February 2012
  Estimated Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)